NICE stands firm, but the public must learn to respect rationing

When the High Court upheld NICE guidance on Alzheimer's drugs, it was seen as an endorsement of its fairness and credibility. But unless the public is better informed of resource issues, unrealistic demands for new drugs will continue to be an issue, writes Helen Mooney

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access